鲁抗医药：关于使用部分闲置募集资金临时补充流动资金的公告

Group 1 - The core point of the article is that LuKang Pharmaceutical announced the use of idle raised funds to temporarily supplement its working capital [2] - The company will utilize 200 million yuan of temporarily idle raised funds for this purpose [2] - The approval for this decision was made during the 12th (temporary) meeting of the 11th Board of Directors held on January 23, 2026 [2] Group 2 - The duration for using the funds is set to be no more than 12 months from the date of the board's approval [2]